SCHEMBL4132738

SCHEMBL4132738

CN(c1ccc(-c2cc(Cl)nc(N3CCOCC3)n2)cc1)S(C)(=O)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
SLC2A2 P11168 1/20 0.44
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PIK3CA P42336 7/20 0.41
MTOR P42345 5/20 0.41
PIK3R1 P27986 1/20 0.40
PIK3CG P48736 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4122923 0.83 PIK3CA (0.57) PIK3CAMTORPIK3R1PIK3CG
SCHEMBL3450472 0.77 KDM4E (0.54) TDP1KDM4ELMNAL3MBTL1HSD17B10
SCHEMBL3991612 0.77 MTOR (0.46) TDP1KDM4ELMNAL3MBTL1HSD17B10
SCHEMBL3452085 0.77 NPSR1 (0.65) TDP1KDM4ELMNAL3MBTL1HSD17B10
SCHEMBL3998571 0.76 ALDH3A1 (0.53) TDP1KDM4ELMNAL3MBTL1HSD17B10
SCHEMBL3991686 0.76 TDP1 (0.51) TDP1KDM4ELMNAL3MBTL1HSD17B10
SCHEMBL13588461 0.74 MOK (0.60) KDM4EPIK3CAMTORPIK3CGHPGD
SCHEMBL3991683 0.74 TDP1 (0.48) TDP1KDM4ELMNAL3MBTL1HSD17B10
SCHEMBL2812564 0.73 PIK3CA (0.64) LMNAHSD17B10POLBHTTGPR55
SCHEMBL4927627 0.72 TDP1 (0.48) TDP1KDM4ELMNAL3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009066084-A1 2 -MORPHOLINOPYRIMIDINES AND THEIR USE AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-28 WO disclosed